{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T19:34:32Z","timestamp":1790883272726,"version":"4.1.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T00:00:00Z","timestamp":1724371200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"publisher","award":["T32HL098036"],"award-info":[{"award-number":["T32HL098036"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","jvascsurg.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Vascular Surgery"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.jvs.2024.08.033","type":"journal-article","created":{"date-parts":[[2024,8,27]],"date-time":"2024-08-27T08:59:47Z","timestamp":1724749187000},"page":"200-209.e3","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Markers of optimal medical therapy are associated with improved limb outcomes after elective revascularization for intermittent claudication"],"prefix":"10.1016","volume":"81","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4636-2157","authenticated-orcid":false,"given":"Marissa C.","family":"Jarosinski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9786-933X","authenticated-orcid":false,"given":"Muhammed S.","family":"Hafeez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie D.","family":"Sridharan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth A.","family":"Andraska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph M.","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yekaterina","family":"Khamzina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5762-6798","authenticated-orcid":false,"given":"Edith","family":"Tzeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine M.","family":"Reitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jvs.2024.08.033_bib1","doi-asserted-by":"crossref","first-page":"e171","DOI":"10.1161\/CIR.0000000000001005","article-title":"Lower extremity peripheral artery disease: contemporary epidemiology, management gaps, and future directions: a scientific statement from the American Heart Association","volume":"144","author":"Criqui","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.jvs.2024.08.033_bib2","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/8295054","article-title":"Burden of coronary artery disease and peripheral artery disease: a literature review","volume":"2019","author":"Bauersachs","year":"2019","journal-title":"Cardiovasc Ther"},{"key":"10.1016\/j.jvs.2024.08.033_bib3","doi-asserted-by":"crossref","first-page":"e71","DOI":"10.1016\/j.jacc.2016.11.007","article-title":"2016 AHA\/ACC guideline on the management of patients with lower extremity peripheral artery disease: a report of the American College of Cardiology\/American Heart Association task force on clinical practice guidelines","volume":"69","author":"Gerhard-Herman","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jvs.2024.08.033_bib4","doi-asserted-by":"crossref","first-page":"2S","DOI":"10.1016\/j.jvs.2014.12.009","article-title":"Society for Vascular Surgery practice guidelines for atherosclerotic occlusive disease of the lower extremities: management of asymptomatic disease and claudication","volume":"61","author":"Conte","year":"2015","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2024.08.033_bib5","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1016\/j.jacc.2024.02.013","article-title":"2024 ACC\/AHA\/AACVPR\/APMA\/ABC\/SCAI\/SVM\/SVN\/SVS\/SIR\/VESS guideline for the management of lower extremity peripheral artery disease: a report of the American College of Cardiology\/American Heart Association joint committee on clinical practice guidelines","volume":"83","author":"Writing Committee","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jvs.2024.08.033_bib6","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jvs.2015.01.051","article-title":"Association of dual-antiplatelet therapy with reduced major adverse cardiovascular events in patients with symptomatic peripheral arterial disease","volume":"62","author":"Armstrong","year":"2015","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2024.08.033_bib7","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1016\/j.jvs.2018.02.047","article-title":"A\u00a0systematic review of the efficacy of aspirin monotherapy versus other antiplatelet therapy regimens in peripheral arterial disease","volume":"67","author":"Beiswenger","year":"2018","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2024.08.033_bib8","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1007\/s00330-012-2441-2","article-title":"Management of peripheral arterial interventions with mono or dual antiplatelet therapy--the MIRROR study: a randomised and double-blinded clinical trial","volume":"22","author":"Tepe","year":"2012","journal-title":"Eur Radiol"},{"key":"10.1016\/j.jvs.2024.08.033_bib9","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(96)09457-3","article-title":"A\u00a0randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee","volume":"348","author":"Committee","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.jvs.2024.08.033_bib10","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1001\/jamacardio.2021.3979","article-title":"Association of smoking with Postprocedural complications following open and endovascular interventions for intermittent claudication","volume":"7","author":"Reitz","year":"2022","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jvs.2024.08.033_bib11","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1161\/CIRCULATIONAHA.117.032361","article-title":"Association of statin dose with amputation and survival in patients with peripheral artery disease","volume":"137","author":"Arya","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.jvs.2024.08.033_bib12","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.jvs.2006.12.054","article-title":"Randomized trial of the effects of cholesterol-lowering with simvastatin on peripheral vascular and other major vascular outcomes in 20,536 people with peripheral arterial disease and other high-risk conditions","volume":"45","year":"2007","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2024.08.033_bib13","article-title":"Antiplatelet agents for intermittent claudication","volume":"11","author":"Wong","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jvs.2024.08.033_bib14","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.jvs.2020.10.090","article-title":"Intermittent claudication treatment patterns in the commercially insured non-Medicare population","volume":"74","author":"Siracuse","year":"2021","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2024.08.033_bib15","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.jvs.2018.05.222","article-title":"Optimal medical management before lower extremity bypass for claudication in the veteran population","volume":"69","author":"Williams","year":"2019","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2024.08.033_bib16","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.jvs.2022.05.016","article-title":"Underutilization of medical management of peripheral artery disease among patients with claudication undergoing lower extremity bypass","volume":"76","author":"Howard","year":"2022","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2024.08.033_bib17","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.jacc.2014.12.043","article-title":"Supervised exercise, stent revascularization, or medical therapy for claudication due to aortoiliac peripheral artery disease: the CLEVER study","volume":"65","author":"Murphy","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jvs.2024.08.033_bib18","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1016\/j.jvs.2008.06.016","article-title":"Cost-effectiveness of endovascular revascularization compared to supervised hospital-based exercise training in patients with intermittent claudication: a randomized controlled trial","volume":"48","author":"Spronk","year":"2008","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2024.08.033_bib19","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1253\/circj.CJ-10-0077","article-title":"Long-term clinical outcome after endovascular treatment in patients with intermittent claudication due to iliofemoral artery disease","volume":"74","author":"Soga","year":"2010","journal-title":"Circ J"},{"key":"10.1016\/j.jvs.2024.08.033_bib20","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.jvs.2011.10.128","article-title":"Results for primary bypass versus primary angioplasty\/stent for intermittent claudication due to superficial femoral artery occlusive disease","volume":"55","author":"Siracuse","year":"2012","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2024.08.033_bib21","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/j.jvs.2022.10.025","article-title":"Early peripheral vascular interventions for claudication are associated with higher rates of late interventions and progression to chronic limb threatening ischemia","volume":"77","author":"Sorber","year":"2023","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2024.08.033_bib23","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1016\/j.jvs.2012.03.016","article-title":"The society for vascular surgery vascular quality initiative","volume":"55","author":"Cronenwett","year":"2012","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2024.08.033_bib24","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1001\/jamasurg.2021.0528","article-title":"STROBE reporting guidelines for observational studies","volume":"156","author":"Ghaferi","year":"2021","journal-title":"JAMA Surg"},{"key":"10.1016\/j.jvs.2024.08.033_bib25","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.avsg.2020.01.015","article-title":"Assessment of the risk analysis index for prediction of mortality, major complications, and Length of Stay in patients who underwent vascular surgery","volume":"66","author":"Rothenberg","year":"2020","journal-title":"Ann Vasc Surg"},{"key":"10.1016\/j.jvs.2024.08.033_bib26","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ypmed.2016.07.006","article-title":"A\u00a0systematic review of interventions to improve adherence to statin medication: what do we know about what works?","volume":"90","author":"Rash","year":"2016","journal-title":"Prev Med"},{"key":"10.1016\/j.jvs.2024.08.033_bib27","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.c117","article-title":"Is a subgroup effect believable? Updating criteria to evaluate the credibility of subgroup analyses","volume":"340","author":"Sun","year":"2010","journal-title":"BMJ"},{"key":"10.1016\/j.jvs.2024.08.033_bib28","doi-asserted-by":"crossref","first-page":"268","DOI":"10.7326\/M16-2607","article-title":"Sensitivity analysis in observational research: Introducing the E-value","volume":"167","author":"VanderWeele","year":"2017","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jvs.2024.08.033_bib29","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.avsg.2017.05.030","article-title":"Vascular study group of G. Risk factors for Suboptimal utilization of statins and antiplatelet therapy in patients undergoing revascularization for symptomatic peripheral arterial disease","volume":"46","author":"Meltzer","year":"2018","journal-title":"Ann Vasc Surg"},{"key":"10.1016\/j.jvs.2024.08.033_bib30","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.jvs.2023.05.006","article-title":"Baseline modern medical management in the BEST-CLI trial","volume":"78","author":"Menard","year":"2023","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2024.08.033_bib31","article-title":"Adherence to guideline-recommended therapy is associated with decreased major adverse cardiovascular events and major adverse limb events among patients with peripheral arterial disease","volume":"3","author":"Armstrong","year":"2014","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jvs.2024.08.033_bib32","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1001\/jamasurg.2016.0415","article-title":"Efficacy of a guideline-recommended risk-reduction Program to improve cardiovascular and limb outcomes in patients with peripheral arterial disease","volume":"151","author":"Hussain","year":"2016","journal-title":"JAMA Surg"},{"key":"10.1016\/j.jvs.2024.08.033_bib33","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.jcin.2022.09.022","article-title":"Guideline-directed medical therapy and long-term mortality and amputation outcomes in patients undergoing peripheral vascular interventions","volume":"16","author":"Smolderen","year":"2023","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jvs.2024.08.033_bib34","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jvs.2014.05.093","article-title":"Statin therapy after infrainguinal bypass surgery for critical limb ischemia is associated with improved 5-year survival","volume":"61","author":"Suckow","year":"2015","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2024.08.033_bib35","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1177\/1358863X19894055","article-title":"Statin therapy for reduction of cardiovascular and limb-related events in critical limb ischemia: a systematic review and meta-analysis","volume":"25","author":"Kokkinidis","year":"2020","journal-title":"Vasc Med"},{"key":"10.1016\/j.jvs.2024.08.033_bib36","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1056\/NEJMoa2000052","article-title":"Rivaroxaban in peripheral artery disease after revascularization","volume":"382","author":"Bonaca","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jvs.2024.08.033_bib37","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.ejvs.2021.01.020","article-title":"The Voyager PAD trial in a surgical Perspective: a debate","volume":"61","author":"Vahl","year":"2021","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.jvs.2024.08.033_bib38","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1007\/s11606-010-1609-1","article-title":"Healthy user and related biases in observational studies of preventive interventions: a primer for physicians","volume":"26","author":"Shrank","year":"2011","journal-title":"J\u00a0Gen Intern Med"},{"key":"10.1016\/j.jvs.2024.08.033_bib39","doi-asserted-by":"crossref","DOI":"10.1001\/jamasurg.2020.0416","article-title":"Association between preoperative metformin exposure and postoperative outcomes in adults with type 2 diabetes","volume":"155","author":"Reitz","year":"2020","journal-title":"JAMA Surg"},{"key":"10.1016\/j.jvs.2024.08.033_bib40","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1001\/jamasurg.2022.7659","article-title":"Assessing the prevalence of medical optimization therapy in vascular surgery clinics","volume":"158","author":"Jano","year":"2023","journal-title":"JAMA Surg"},{"key":"10.1016\/j.jvs.2024.08.033_bib41","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1161\/CIRCULATIONAHA.109.873232","article-title":"The polypill in the prevention of cardiovascular diseases: key concepts, current status, challenges, and future directions","volume":"122","author":"Lonn","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.jvs.2024.08.033_bib42","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1056\/NEJMoa2028220","article-title":"Polypill with or without aspirin in persons without cardiovascular disease","volume":"384","author":"Yusuf","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jvs.2024.08.033_bib43","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.jvs.2017.12.044","article-title":"Active smoking in claudicants undergoing lower extremity bypass predicts decreased graft patency and worse overall survival","volume":"68","author":"Jones","year":"2018","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2024.08.033_bib44","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.jvs.2017.10.091","article-title":"The impact of current smoking on outcomes after infrainguinal bypass for claudication","volume":"68","author":"Kalbaugh","year":"2018","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2024.08.033_bib45","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jvs.2005.03.024","article-title":"Smoking and the patency of lower extremity bypass grafts: a meta-analysis","volume":"42","author":"Willigendael","year":"2005","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2024.08.033_bib46","article-title":"Endovascular revascularisation versus conservative management for intermittent claudication","volume":"3","author":"Fakhry","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jvs.2024.08.033_bib47","first-page":"e1082","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology\/American Heart Association task force on clinical practice guidelines","volume":"139","author":"Grundy","year":"2019","journal-title":"Circulation"}],"container-title":["Journal of Vascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0741521424017853?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0741521424017853?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T10:57:52Z","timestamp":1734001072000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0741521424017853"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S0741521424017853"],"URL":"https:\/\/doi.org\/10.1016\/j.jvs.2024.08.033","relation":{},"ISSN":["0741-5214"],"issn-type":[{"value":"0741-5214","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Markers of optimal medical therapy are associated with improved limb outcomes after elective revascularization for intermittent claudication","name":"articletitle","label":"Article Title"},{"value":"Journal of Vascular Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jvs.2024.08.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc. on behalf of the Society for Vascular Surgery.","name":"copyright","label":"Copyright"}]}}